CROCS INC (CROX)

US2270461096 - Common Stock

101.6  +3.01 (+3.05%)

Fundamental Rating

7

Taking everything into account, CROX scores 7 out of 10 in our fundamental rating. CROX was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CROX is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make CROX suitable for value and quality investing!



9

1. Profitability

1.1 Basic Checks

In the past year CROX was profitable.
CROX had a positive operating cash flow in the past year.
In the past 5 years CROX has always been profitable.
In the past 5 years CROX always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of CROX (17.71%) is better than 94.00% of its industry peers.
CROX has a better Return On Equity (48.39%) than 98.00% of its industry peers.
CROX has a better Return On Invested Capital (21.93%) than 90.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CROX is significantly above the industry average of 11.54%.
The 3 year average ROIC (30.08%) for CROX is well above the current ROIC(21.93%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 17.71%
ROE 48.39%
ROIC 21.93%
ROA(3y)25.34%
ROA(5y)24.04%
ROE(3y)1755.79%
ROE(5y)1093.13%
ROIC(3y)30.08%
ROIC(5y)27.47%

1.3 Margins

With an excellent Profit Margin value of 20.50%, CROX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CROX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 26.15%, CROX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CROX has grown nicely.
CROX's Gross Margin of 58.15% is fine compared to the rest of the industry. CROX outperforms 74.00% of its industry peers.
In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 26.15%
PM (TTM) 20.5%
GM 58.15%
OM growth 3Y13.61%
OM growth 5Y32.68%
PM growth 3Y-3.95%
PM growth 5YN/A
GM growth 3Y1.02%
GM growth 5Y1.62%

7

2. Health

2.1 Basic Checks

CROX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
CROX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CROX has less shares outstanding
The debt/assets ratio for CROX has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.79 indicates that CROX is not in any danger for bankruptcy at the moment.
The Altman-Z score of CROX (3.79) is better than 74.00% of its industry peers.
The Debt to FCF ratio of CROX is 1.51, which is an excellent value as it means it would take CROX, only 1.51 years of fcf income to pay off all of its debts.
CROX has a Debt to FCF ratio of 1.51. This is in the better half of the industry: CROX outperforms 70.00% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that CROX is somewhat dependend on debt financing.
CROX has a Debt to Equity ratio of 0.82. This is in the lower half of the industry: CROX underperforms 72.00% of its industry peers.
Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 1.51
Altman-Z 3.79
ROIC/WACC2.49
WACC8.81%

2.3 Liquidity

CROX has a Current Ratio of 1.43. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
CROX has a Current ratio of 1.43. This is in the lower half of the industry: CROX underperforms 78.00% of its industry peers.
A Quick Ratio of 0.90 indicates that CROX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.90, CROX is doing worse than 68.00% of the companies in the same industry.
The current and quick ratio evaluation for CROX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.9

6

3. Growth

3.1 Past

CROX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.17%, which is quite good.
The Earnings Per Share has been growing by 55.01% on average over the past years. This is a very strong growth
CROX shows a small growth in Revenue. In the last year, the Revenue has grown by 3.16%.
The Revenue has been growing by 29.49% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)9.17%
EPS 3Y55.01%
EPS 5YN/A
EPS Q2Q%10.77%
Revenue 1Y (TTM)3.16%
Revenue growth 3Y41.93%
Revenue growth 5Y29.49%
Sales Q2Q%1.58%

3.2 Future

The Earnings Per Share is expected to grow by 8.43% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.89% on average over the next years.
EPS Next Y9.54%
EPS Next 2Y5.59%
EPS Next 3Y5.95%
EPS Next 5Y8.43%
Revenue Next Year2.92%
Revenue Next 2Y3.02%
Revenue Next 3Y3.48%
Revenue Next 5Y6.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

9

4. Valuation

4.1 Price/Earnings Ratio

CROX is valuated cheaply with a Price/Earnings ratio of 7.69.
Based on the Price/Earnings ratio, CROX is valued cheaply inside the industry as 96.00% of the companies are valued more expensively.
CROX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.65.
Based on the Price/Forward Earnings ratio of 7.57, the valuation of CROX can be described as very cheap.
94.00% of the companies in the same industry are more expensive than CROX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.56, CROX is valued rather cheaply.
Industry RankSector Rank
PE 7.69
Fwd PE 7.57

4.2 Price Multiples

CROX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CROX is cheaper than 80.00% of the companies in the same industry.
CROX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CROX is cheaper than 86.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.3
EV/EBITDA 6.18

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of CROX may justify a higher PE ratio.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y5.59%
EPS Next 3Y5.95%

0

5. Dividend

5.1 Amount

No dividends for CROX!.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (11/21/2024, 2:21:09 PM)

101.6

+3.01 (+3.05%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.92B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 7.69
Fwd PE 7.57
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.81
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.71%
ROE 48.39%
ROCE
ROIC
ROICexc
ROICexgc
OM 26.15%
PM (TTM) 20.5%
GM 58.15%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.43
Quick Ratio 0.9
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)9.17%
EPS 3Y55.01%
EPS 5Y
EPS Q2Q%
EPS Next Y9.54%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.16%
Revenue growth 3Y41.93%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y